Company Profiles

driven by the PitchBook Platform

Adjuvant Therapeutics

Description

Developer of cancer treatment technologies. The company offers a system called OncO2, that increase oxygen concentrations in tumors, to improve the effectiveness of radiotherapy for cancer treatment.

PRIVATE

Status

1-10

Employees

Accelerator/Inc

Latest Deal Type

1

Investors

Description

Developer of cancer treatment technologies. The company offers a system called OncO2, that increase oxygen concentrations in tumors, to improve the effectiveness of radiotherapy for cancer treatment.

Website:

www.adjuvanttherapeutics.com

Ownership Status

Privately held (backing)

Financing Status

Accelerator/Incubator Backed

Primary Industry

Other Healthcare Technology Systems

Primary Office

1344 Summer Street Suite 311.1 Halifax, Nova Scotia B3H 0A8Canada +1 (902) 442-7602
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Adjuvant Therapeutics's full profile, request a free trial.

Adjuvant Therapeutics Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Adjuvant Therapeutics Investors (1)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
InnovacorpVenture CapitalMinority000 0000000 0000
Innovacorp Venture Capital

Adjuvant Therapeutics Executive Team (1)

NameTitleBoard
Seat
Contact
Info
Cliff AnselChief Executive Officer
Cliff Ansel Chief Executive Officer
Request full access to PitchBook